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Bacterial surface structures such as capsules and adhesins are generally regarded as important virulence
factors. Here we demonstrate that capsules block the function of the self-recognizing protein antigen 43
through physical shielding. The phenomenon is not restricted to Escherichia coli but can occur in other
gram-negative bacteria. Likewise, we show that other short adhesins exemplified by the AIDA-I protein are
blocked by the presence of a capsule. The results support the notion that capsule polysaccharides sterically
prevent receptor-target recognition of short bacterial adhesins. This negative interference has important
biological consequences, such as affecting the ability of bacteria to form biofilms.
All members of the Enterobacteriaceae are able to elaborate
a layer of surface-associated polysaccharides called the cap-
sule. The composition of these capsular polysaccharides is very
much strain dependent. In Escherichia coli it may be one of the
80 distinct polysaccharides (designated the K antigens) or a
polymer derived from the 170 different O antigens. In effect,
whereas all polysaccharide K antigens form a capsule struc-
ture, the inverse is not always true: not all capsules are com-
posed of K antigens (53).
Capsule polysaccharides provide protection against desicca-
tion and attack from phages, however, they are first and fore-
most recognized virulence determinants. It has been known for
years that some capsular antigens, notably K1 and certain types
of O antigen, are strongly associated with extraintestinal infec-
tions such as septicemia, meningitis, and urinary tract infection
(UTI) (19, 25, 28, 32, 46). E. coli strains of serotype K1 rep-
resent 80% of all E. coli strains isolated from cases of newborn
meningitis and sepsis in humans. Also, K1 strains are often
implicated in UTI. The K1 capsule is a linear homopolymer of
sialic acid residues. The capsule is identical to the polysialic
acid found on certain human cells and is poorly immunogenic
due to molecular mimicry of host structures (49). Strains caus-
ing UTI, meningitis, and sepsis are generally resistant to the
bactericidal action of human serum (reviewed in references 34,
53). Furthermore, K1 capsules are antiphagocytic, arguably a
trait that would be helpful to a bacterium for survival in blood
and tissue.
Another group of virulence factors is constituted by the
bacterial adhesins, protein structures that recognize a wide
range of molecular motifs and provide targeting of the bacteria
to specific tissue surfaces in the host (for a recent review, see
reference 24). While most adhesins recognize nonself targets
present in the environment (e.g., a specific saccharide), some
mediate self-recognition.
Antigen 43 (Ag43) is exceptional in being such a self-recog-
nizing adhesin (15, 21). Ag43 is a surface protein that confers
bacterial cell-to-cell aggregation, a trait that can be visualized
macroscopically as flocculation and settling of cells from static
liquid suspensions; hence, the gene name flu was originally
coined for the corresponding genetic locus (12). In an inde-
pendent study, a major E. coli outer membrane protein antigen
was investigated by virtue of its aggregative properties and
termed Ag43 (29). Only later was Ag43 identified as the prod-
uct of the flu gene (15, 18). In line with the gene product name
Ag43, the term agn43 is also frequently used for the corre-
sponding gene instead of flu. Ag43 expression confers a char-
acteristic frizzy colony morphology (16). Expression is phase
variable with switching rates of 103 per cell per generation
under normal growth conditions due to the concerted action of
the Dam methylase (positive regulation) and the OxyR redox
sensor (negative regulation) (18, 38, 41, 52). Ag43 is an auto-
transporter protein, and all information required for traverse
of the bacterial membrane system and final routing to the
surface resides in the protein itself. This is also supported by
the fact that Ag43 can be expressed in a wide range of gram-
negative bacteria (20, 21). In E. coli, Ag43 is present in
50,000 copies per cell (30). It is processed into two subunits,
 and , each constituting about half of the protein. The 
subunit is an outer membrane component that presumably
forms a pore through which Ag43 gains access to the surface.
The  subunit remains attached to the cell surface via inter-
action with the  subunit but can be detached by brief heat
treatment (18).
Expression of Ag43 dramatically enhances biofilm formation
in bacteria (9, 21, 22, 23), and Ag43 expression in E. coli is
specifically correlated with the biofilm mode of growth (39).
Conversely, lesions in the flu gene causing abolishment of
Ag43 expression in many cases result in cells with a very limited
ability to form a biofilm (9, 22, 39). Biofilm formation is often
correlated with bacterial virulence (8, 37). Expression of Ag43
was recently reported to be correlated with biofilm formation
by uropathogenic E. coli during infection of bladder cells (1).
Furthermore, Ag43-mediated cell aggregation was found to
protect bacteria against killing agents like hydrogen peroxide
(38). Ag43 is widespread in E. coli, and it is expressed in many
pathogenic strains. A survey of enteropathogenic and UTI
strains showed that 77 and 60%, respectively, of these were
capable of Ag43 expression (31). Also, many strains possess
duplex or multiple copies of the gene, as seems to be the case
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with enteropathogenic and enterohemorrhagic subtypes (23,
35, 48). Ag43 exhibits significant homology to several other
members of the autotransporter protein family; for example,
the primary structure of the AIDA-I adhesin, involved in dif-
fuse adherence of enteropathogenic E. coli strains, shows
31% identity to Ag43 (5).
Both Ag43 and capsules seem to play important roles in
bacterial survival and pathogenicity. However, while Ag43 pro-
trudes 10 nm beyond the outer membrane (23), the capsule
may extend 0.2 to 1.0 m from the bacterial surface, depending
on its type and composition. On one hand, the capsule consti-
tutes a somewhat ephemeral structure that might not interfere
with the close cellular contact required for intercellular Ag43
contact. On the other hand, it could be that the presence of a
capsule would sterically shield Ag43 and abolish Ag43-Ag43-
mediated cell aggregation. To resolve this apparent paradox,
we investigated possible interference between Ag43 and cap-
sule.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains and plasmids used in this
study are listed in Table 1. Cells were grown at 37°C on solid or in liquid
Luria-Bertani (LB) medium supplemented with the appropriate antibiotics un-
less otherwise stated.
Construction of an oxyR::kan mutant. An E. coli MG1655 oxyR::kan mutant
was constructed by using the  Red recombinase gene replacement system (10).
Briefly, the kanamycin gene from plasmid pKD4 was amplified by primers con-
taining 40-nucleotide oxyR homology extensions (288, 5-GGCTGAACACCGC
CATTTTCGGCGTGCGGCAGATTCCTGCGTGTAGGCTGGAGCTGC
TTC, and 289, 5-CGCGGATGGCCTCTGCCAGCTGCTCATAGCGGCTGC
GCAGCATATGAATATCCTCCTTAG). This product was digested with DpnI
and transformed into MG1655(pKD46), and kanamycin-resistant colonies were
selected. The correct double-crossover and recombination event was confirmed
by PCR and Southern blotting. The  Red helper plasmid pKD46 was cured by
growth at 37°C, and the subsequent strain was designated MS641.
DNA manipulations. Isolation of plasmid DNA was carried out with the
QIAprep Spin miniprep kit (Qiagen). Restriction endonucleases were used ac-
cording to the manufacturer’s specifications (Biolabs). PCRs were made as
previously described (44). Amplified products were sequenced to ensure fidelity
of the PCR by using the ABI PRISM BigDye Terminator cycle sequencing ready
reaction kit (PE Applied Biosystems). Samples were run on an ABI PRISM 310
genetic analyzer (PE Applied Biosystems) as described in the manufacturer’s
specifications.
Immunofluorescence microscopy. Surface presentation of Ag43 was assessed
by immunofluorescence microscopy employing a polyclonal rabbit antiserum
raised against the  subunit of Ag43. A fluorescein isothiocyanate-labeled anti-
rabbit serum was used as a secondary antibody (Sigma). Cell fixation, immuno-
labeling, and microscopy were carried out as previously described (16).
Colony morphology. Colony morphology was assayed by employing a Carl
Zeiss Axioplan epifluorescence microscope, and digital images were captured
with a 12-bit cooled slow-scan charge-coupled device camera (KAF 1400 chip;
Photometrics, Tucson, Ariz.) controlled by the PMIS software (Photometrics).
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant characteristic(s) Reference or source
E. coli strains
1177 UTI isolate (O1:K1:H7) 7
CN1016 1177 fim::kan 7
MG1655 K-12 reference strain 2
MS427 MG1655 flu 33
MS428 MG1655 fim 22
MS528 MG1655 flu fim 22
MS641 MG1655 oxyR::kan This study
DD14 MS427 containing pKKJ128 and pBR322 This study
DD19 MS641 containing pBR322 This study
DD26 MS641 containing pKT274 This study
DD27 MS641 containing pIR100 This study
DD34 MS427 containing pACYC184 and pKT274 This study
DD35 MS427 containing pACYC184 and pIR100 This study
DD36 MS427 containing pACYC184 and pBR322 This study
DD37 MS427 containing pKKJ128 and pKT274 This study
DD38 MS427 containing pKKJ128 and pIR100 This study
MS718 MS428 containing pFCH2235 This study
PK1081 CN1016 containing pFCH2235 This study
K. pneumoniae strains
C105 K35 capsule 45
C105 NCV Spontaneous C105 NCV 45
LH71 C105 containing pIB264 This study
LH72 C105 NCV containing pIB264 This study
PK1013 C105 containing pHHA147 This study
PK1014 C105 NCV containing pHHA147 This study
PK1016 C105 containing pBR322 This study
PK1021 C105 NCV containing pBR322 This study
Plasmids
pFHC2235 IPTG-inducible dam gene in pUC19a Gift from F. G. Hansen
pHHA147 flu gene from MG1655 in pBR322 38
pIR100 E. coli K5 capsule gene operon in pBR322(cos4) Gift from I. Roberts
pKKJ128 flu gene from MG1655 in pACYC184 21
pKT274 E. coli K1 capsule gene operon in pHC79 13
pKKJ101 flu gene in pUCP22 21
pIB264 AIDA-I autotransporter and glycosylation genes in pBR322 4
a IPTG, isopropyl--D-thiogalactopyranoside.
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Biofilm assay. Biofilm formation on plastic surfaces was monitored in 96-well
polystyrene microtiter plates. Cells were grown statically for 24 h in LB medium
at 37°C, washed to remove unbound cells, and stained with crystal violet as
previously reported (40). Quantification of bound cells was performed by addi-
tion of acetone-ethanol (20:80) and measurement of the dissolved crystal violet
at an optical density of 600 nm.
Cell adhesion assay. Adherence of bacteria to mammalian HT29 colon cancer
cells was performed as follows. A monolayer of cells was grown to 95% conflu-
ence in standard tissue culture medium. Exponentially growing bacterial cells
were harvested, washed, and resuspended in phosphate-buffered saline (contain-
ing 0.5% methyl--D-mannopyranoside to rule out any contribution from type 1
fimbriae) at a concentration of 108 cells per ml. Bacteria were incubated together
with the HT29 cells for 2 h at 37°C, and afterwards, nonadhered bacteria were
removed by extensive washing with phosphate-buffered saline. The cells were
then fixed with 70% ice-cold methanol for 15 min and examined by phase-
contrast microscopy.
RESULTS
Ag43 function is inhibited in a wild-type encapsulated uro-
pathogenic E. coli strain. Expression of Ag43 is positively reg-
ulated by Dam methyltransferase. We have previously found
that the presence of type 1 fimbriae sterically blocks intercel-
lular Ag43-Ag43 interaction (15) and also affects its expression
(41, 42). Accordingly, when the E. coli K-12 strain MS428, a
fim derivative of the K-12 reference strain MG1655, was trans-
formed with the high-copy-number plasmid pFHC2235 (en-
coding the dam methyltransferase gene) we expected it to
produce high levels of Ag43 by virtue of the enhanced level
of the Dam protein. In line with this tenet, the MS428
(pFHC2235) transformant produced colonies with a frizzy
FIG. 1. Colony morphology (A), cell-cell autoaggregation (B), phase-contrast microscopy (C), and immunofluorescence microscopy with
anti-Ag43 serum (D) of (i) E. coli MS428 (MG1655 fim), (ii) E. coli MS428 harboring pFCH2235 (induced with isopropyl--D-thiogalactopyr-
anoside [IPTG] for Dam overexpression), (iii) E. coli CN1016 (1177 fim), and (iv) E. coli CN1016 harboring pFCH2235 (induced with IPTG for
Dam overexpression). The frizzy colony morphology and cell-cell aggregation imparted by Dam-induced expression of Ag43 are not observed in
the K1 capsulated UTI fim mutant strain CN1016.
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FIG. 2. Colony morphology (A), cell-cell autoaggregation (B), phase-contrast microscopy (C), and immunofluorescence microscopy with
anti-Ag43 serum (D) of E. coli MS427 (MG1655 	flu) harboring (i) pACYC184 and pBR322 (control), (ii) pKKJ128 and pBR322 (Ag43), (iii)
pACYC184 and pKT274 (K1), (iv) pACYC184 and pIR100 (K5), (v) pKKJ128 and pKT274 (Ag43 K1), or (vi) pKKJ128 and pIR100
(Ag43 K5). The frizzy colony morphology and cell-cell aggregation imparted by Ag43 are prevented by the concomitant surface expression of
either a K1 or K5 capsule.
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morphology and aggregating cells that settled from static liquid
solutions, i.e., traits that were indicative of high levels of Ag43
production (Fig. 1).
The uropathogenic E. coli strain 1177 of serotype O1:K1:H7
was previously studied, and a derivative, CN1016, deficient in
expression of type 1 fimbriae was constructed (7). Strain 1177
has at least one copy of the flu gene on the chromosome (our
unpublished data). When the pFHC2235 plasmid was intro-
duced into these strains, we expected it to induce production of
high levels of Ag43 in line with the K-12 control. However, the
frizzy colony morphology, aggregation, and cell settling profiles
we expected (at least in the case of the Fim-negative CN1016
[pFHC2235] strain) were not observed (Fig. 1). We therefore
speculated whether a surface feature other than type 1 fim-
briae could interfere with the expression or function of Ag43.
Although this strain is also able to produce P-fimbriae, over-
expression of the Dam protein prevents transition from the
phase on to the phase off state (6), and we observed that only
a small proportion (less than 5%) of the colonies produced
these organelles. A good candidate therefore seemed to be the
K1 capsule of 1177 and derivatives.
Ag43 function is blocked upon capsule expression in E. coli
K-12. Unlike many wild-type strains, E. coli K-12 strains are
normally incapable of producing extended surface-associated
polysaccharides and produce rough colonies; the polysaccha-
ride has a complete core but no O antigen due to the insertion
of an IS5 element in the rfb gene cluster controlling O antigen
biosynthesis (27). This makes K-12 a perfect test bed for mon-
itoring potential interference of capsular polysaccharides with
Ag43. When plasmids carrying the gene cluster required for
either K1 or K5 capsule production were introduced in strain
MG1655, colonies with a characteristic smooth appearance
resulted (Fig. 1). It should be noted that we also used a version
of MG1655 (i.e., strain MS427) where the flu gene was deleted
from the chromosome (33). Such cells do not aggregate or
settle from liquid suspension. Meanwhile, expression of Ag43
in MS427 resulted in cells which formed frizzy colonies, aggre-
gated, and settled from static liquid suspensions (Fig. 2). When
cells were forced to concomitantly express both surface factors,
i.e., capsule and Ag43, the capsule phenotype was dominant
and the cells were unable to aggregate. This could either be
due to sterical shielding of Ag43 by the capsule or capsule
production somehow interfering with synthesis or transport of
Ag43 to the cell surface. To differentiate between these possi-
bilities, immunofluorescence microscopy was employed (Fig.
2). This demonstrated that the cells did express Ag43 on the
surface and that the signal strengths in capsulated and non-
capsulated pairs of strains were similar, indicative of similar
levels of Ag43 on the surface (Fig. 2). Western blotting of
whole-cell lysates also indicated that similar amounts of Ag43
were present irrespective of encapsulation (data not shown).
When settling assays were performed with these cells, they
were incapable of aggregation (data not shown). Taken to-
gether, the results suggest that a capsule blocks the close cell
contact needed for intercellular Ag43-Ag43 interaction.
We also performed the same experiments with an MG1655
oxyR::kan host. In this host, transcription of the flu gene is
driven from its natural promoter and the absence of OxyR
causes constitutive Ag43 expression. The results indicated that
Ag43 was produced but that its function was blocked by the
capsule (Fig. 3). Arguably, unless OxyR is involved, capsule
production does not seem to influence transcription of the flu
gene and transport of Ag43 to the cell surface. The data sup-
port the notion that a capsule sterically shields Ag43-Ag43
interaction.
FIG. 3. Colony morphology (A) and phase-contrast microscopy (B) of E. coli MS641 (MG1655 oxyR::kan) harboring (i) pBR322 (control), (ii)
pKT274 (K1), or (iii) pIR100 (K5). Derepression of Ag43 expression in the absence of OxyR results in a frizzy colony morphology and
clumping phenotype that is prevented by the concomitant surface expression of a capsule.
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Ag43 function can be restored by capsule loss in Klebsiella
pneumonia. The vast majority of K. pneumoniae strains express
a large polysaccharide capsule. However, noncapsulated vari-
ants (NCVs) arise spontaneously. An isogenic pair of K. pneu-
moniae strain C105 clones, differing only in their ability to
express K35 capsule antigen, was recently characterized (45).
When this C105/C105NCV pair was transformed with plasmid
pHHA147, harboring a constitutively expressed flu gene, a
characteristic frizzy colony morphology resulted in the case of
strain C105NCV(pHHA147), whereas little or no difference in
colony morphology was seen in strain C105(pHHA147) (Fig.
4). Microscopic observation of C105NCV(pHHA147) revealed
the presence of cell aggregates, whereas no aggregates were
observed with C105(pHHA147) cells (Fig. 4). Additionally, we
introduced Ag43-expressing plasmids into a number of other
gram-negative bacteria from the institute strain collection with
a known ability to produce capsules, viz., Enterobacter cloacae,
Serratia liquefaciens, Burkholderia cepacia, and Pseudomonas
aeruginosa. Although Ag43 was expressed on the cell surface,
none of the transformed strains were capable of aggregating or
settling from standing overnight cultures (data not shown).
These observations further bolster the notion of negative in-
terference between capsule and Ag43; they also take it from
being a phenomenon restricted to E. coli to being a general
phenomenon valid in a range of gram-negative bacteria.
Biofilm aspects. We and others have demonstrated that
Ag43 expression confers excellent biofilm forming properties
upon a variety of bacteria (9, 21, 22, 23, 38, 39). Since we have
demonstrated here that the presence of a capsule virtually
abolishes Ag43 functionality, we surmised that encapsulated
cells expressing both capsule and Ag43 would be impaired in
biofilm formation compared to noncapsulated cells. To test
FIG. 4. Colony morphology (A), cell-cell autoaggregation (B), phase-contrast microscopy (C), and immunofluorescence microscopy with
anti-Ag43 serum (D) of the capsule-producing K. pneumoniae strain C105 containing either (i) pBR322 (control) or (ii) pHHA147 (Ag43) and
the capsule-negative strain C105 NCV containing either (iii) pBR322 (control) or (iv) pHHA147 (Ag43). The frizzy colony morphology and
cell-cell aggregation imparted by Ag43 is prevented by the concomitant surface expression of the K. pneumoniae K35 capsule.
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this hypothesis, a set of strains differing in their ability to
produce capsule and Ag43 were investigated for their ability to
form biofilms on an abiotic surface (in this case polystyrene
microtiter plates). Our results revealed that in capsulated cells
expression of Ag43 did not improve biofilm formation, whereas
in a noncapsulated strain a significant improvement was ob-
served when Ag43 was expressed (Fig. 5). It should also be
noted that when the capsulated and noncapsulated pair of
strains were compared, the noncapsulated variant appeared to
be a slightly better biofilm former. This is probably due to
capsule shielding of other (non-Ag43) factors that improve
biofilm formation.
The action of other autotransporter adhesins similar to
Ag43 is abolished by capsule shielding. The AIDA-I autotrans-
porter is a potent adhesin involved in the adherence of enter-
opathogenic E. coli strains to various mammalian cells (4, 5).
The AIDA-I adhesin and Ag43 are predicted to have the same
overall tertiary structure. We speculated that, since capsulation
obstructs the activity of Ag43, it might also interfere with the
activity of similar-sized proteins such as AIDA-I. To test this,
we introduced a plasmid, pIB264, encoding the AIDA-I locus
(4) into a pair of host cells differing in their ability to produce
a capsule, viz., C105 and C105 NCV. The ability of these
strains to adhere to human intestinal cell line cells (HT29 cells)
was assayed. Bacteria producing both AIDA-I and capsule
were unable to adhere, whereas bacteria producing AIDA-I,
but not capsule, bound in large numbers (Fig. 6).
DISCUSSION
Bacteria express a number of surface structures that enable
them to interact with the environment, e.g., flagella for swim-
ming and adhesins for attachment. These surface structures
have a highly diverse size spectrum, and it must be implicit that
sometimes they must interfere physically with each other in
such a way that the function of some will be obstructed by the
presence of other (more extended) structures. As an example,
it was previously demonstrated that fimbriae, which extend 1
m from the bacterial surface, physically block the action of
the much shorter Ag43 in bacteria (15). Based on this obser-
vation, we predict that fimbriae will also block the action of
other adhesins similar in size to Ag43. Such surface structure
interference must have important consequences for the inter-
play of bacteria with the environment. Here, we have studied
the interference between nonfimbrial adhesins and capsule.
Several lines of evidence indicated that Ag43 function was
sterically blocked by extended polysaccharides. In a uropatho-
genic E. coli strain of serotype K1, Ag43 could be expressed but
it was inactive. In E. coli K-12 strains expressing Ag43, aggre-
gation was abolished when these strains were made to express
either K1 or K5 capsules. Furthermore, in a well-characterized
strain set of K. pneumoniae, differing only in capsulation, Ag43
activity was only observed in the NCV. In line with this, Ag43
activity was blocked in a range of bacterial strains, arguably
due to capsule interference. All phenotypic traits associated
with Ag43 were affected: cell aggregation, settling from static
liquid suspension, biofilm formation, and in most cases, colony
morphology. The interference between capsule and Ag43 was
physical in nature rather than by genetic cross talk. Negative
interference between capsule and Ag43 seemed to be a general
phenomenon in a range of gram-negative bacteria and was not
isolated to E. coli. Bacterial capsules might provide various
degrees of blockage depending on their thickness and quantity
and perhaps also on their charge.
An important aspect of this study was the finding that cap-
sulation not only interfered with the function of Ag43 but also
shielded and blocked the action of another autotransporter
adhesin, namely AIDA-I. Both adhesins have been predicted
to protrude 10 nm from the bacterial surface. The implica-
tions of these findings are far-ranging because it means that an
entire class of short nonorganelle bacterial adhesins and inva-
sins are nonfunctional in the presence of a capsule. This class
encompasses not only the autotransporter adhesins and inva-
sins such as TibA, AIDA-I, and Ag43 from enterics but also
autotransporters from a wide spectrum of bacteria, including
pertactin P.69 and TcfA from Bordetella, Hsf from Haemophi-
lus influenzae, and UspA1 from Moraxella catarrhalis (for a
review, see reference 17). Additionally, there are numerous
other nonfimbrial adhesins and invasins exemplified by Afa-I
and intimin (reviewed in references 24 and 43), which would be
candidates for capsule shielding. In line with our data, several
other studies have actually reported that capsulated bacteria
FIG. 5. Biofilm formation by the capsule-producing K. pneumoniae strain C105 containing either (i) pBR322 (control) or (ii) pHHA147
(Ag43) and the capsule-negative strain C105 NCV containing either (iii) pBR322 (control) or (iv) pHHA147 (Ag43). Surface expression of
Ag43 promoted an enhanced biofilm formation phenotype only in the absence of any capsular material. Strains were grown in LB media on
polystyrene microtiter plates. Adhered cells were stained with 0.1% crystal violet, and the absorbance was measured at 600 nm. Shown are the
averages of readings from 3 experiments (
 standard deviation).
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adhere poorly to epithelial cells and exhibit severe reductions
in their abilities to invade compared to their capsulated coun-
terparts (14, 36). In Neisseria meningitidis, the adhesive Opc
protein was reported to be active only in acapsulated strains
(51). A study of E. coli P-fimbrial adhesins expressed in a
nonorganelle context revealed their activity could be blocked
by extensive O antigens (50). Finally, the synthesis of lipopoly-
saccharide by enterohemorrhagic E. coli O157:H7 was shown
to interfere with adherence to HeLa cells in vitro (47).
The capsule shielding concept leaves the bacteria with an
obvious dilemma. They cannot adhere or invade without the as-
sistance of adhesin proteins, but at the same time, the capsule
provides protection against many of the countermeasures at the
disposal of a mammalian host such as phagocytosis or comple-
ment, etc. Arguably, bacteria that use short adhesins and in-
vasins would have to coordinate their expression with that of
capsules. An alternative solution would be to express adhesins
that can penetrate and reach beyond the capsule, viz., fimbriae.
At present, it is hard to say whether bacteria actually coor-
dinate production of capsules and nonorganelle adhesins, and
to our best knowledge, no reports to this end are available
from the literature. The regulation of capsule gene expression
is complex, with overlapping regulatory circuits. Capsule ex-
pression has in many cases been reported to be phase variable,
for example, in Bacteroides fragilis (26), N. meningitidis (11), and
Campylobacter (3). In K. pneumoniae, some types of capsule
production were reported to be influenced by environmental
conditions (14). Arguably, differential expression of capsules
will intermittently result in a noncapsulated state where non-
organelle adhesins like Ag43 and AIDA-I would be exposed.
Ag43 promotes bacterial biofilm formation and aggregation,
both of which are traits closely associated with bacterial viru-
lence (1, 8). Capsulation protects bacteria that live in close
association with a mammalian host against several defense
mechanisms. The future challenge is to decipher how the bac-
teria orchestrate the expression of these two important types of
surface structures to make use of their full survival and viru-
lence capabilities.
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